Triphenyl Phosphate

Triphenyl Phosphate

SCHEMBL4252471

O=P(Oc1ccccc1)(Oc1ccccc1)Oc1ccccc1.[Ru]

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ SRC P12931 1/20 0.61
▸ L3MBTL1 Q9Y468 2/20 0.58
▸ TDP1 Q9NUW8 1/20 0.58
▸ TSHR P16473 2/20 0.54
▸ CYP3A4 P08684 1/20 0.54
▸ KDM4E B2RXH2 1/20 0.52
▸ MEN1 O00255 3/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ HTT P42858 2/20 0.47
▸ LMNA P02545 2/20 0.44
▸ LTA4H P09960 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ RECQL P46063 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ PKM P14618 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Triphenyl Phosphate SCHEMBL28557783 0.97 SRC (0.64) SRCL3MBTL1TDP1TSHRCYP3A4
Triphenyl Phosphate SCHEMBL483692 0.97 SRC (0.64) SRCL3MBTL1TDP1TSHRCYP3A4
Triphenyl Phosphate SCHEMBL28761613 0.97 SRC (0.64) SRCL3MBTL1TDP1TSHRCYP3A4
Triphenyl Phosphate SCHEMBL18116 0.97 SRC (0.64) SRCL3MBTL1TDP1TSHRCYP3A4
Triphenyl Phosphate SCHEMBL9576987 0.94 SRC (0.61) SRCL3MBTL1TDP1TSHRCYP3A4
SCHEMBL10015247 0.94 CYP3A4 (0.61) SRCL3MBTL1TDP1TSHRCYP3A4
Triphenyl Phosphate SCHEMBL16338665 0.94 SRC (0.61) SRCL3MBTL1TDP1TSHRCYP3A4
Triphenyl Phosphate SCHEMBL940487 0.94 SRC (0.61) SRCL3MBTL1TDP1TSHRCYP3A4
Triphenyl Phosphate SCHEMBL7746390 0.94 SRC (0.61) SRCL3MBTL1TDP1TSHRCYP3A4
Triphenyl Phosphate SCHEMBL15815456 0.94 SRC (0.61) SRCL3MBTL1TDP1TSHRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090124772-A1 PROCESS FOR PRODUCING ORGANIC TRANSITION METAL COMPLEX COMPOUND, METATHESIS CATALYST PRODUCED BY USING THE SAME, RING-OPENING METATHESIS POLYMER OBTAINABLE WITH THE METATHESIS CATALYST, AND PROCESS FOR PRODUCING THE POLYMER MITSUI CHEMICALS, INC. (JP) 2009-05-14 — — US disclosed
EP-1950216-A1 PROCESS FOR PRODUCING ORGANIC TRANSITION METAL COMPLEX COMPOUND, METATHESIS CATALYST PRODUCED BY THE PROCESS, METATHESIS POLYMER FORMED BY RING OPENING POLYMERIZATION WITH THE SAME, AND PROCESS FOR PRODUCING POLYMER WITH THE SAME Mitsui Chemicals, Inc. (JP) 2008-07-30 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124772-A1 PROCESS FOR PRODUCING ORGANIC TRANSITION METAL COMPLEX COMPOUND, METATHESIS CATALYST PRODUCED BY USING THE SAME, RING-OPENING METATHESIS POLYMER OBTAINABLE WITH THE METATHESIS CATALYST, AND PROCESS FOR PRODUCING THE POLYMER PORCN, ICMT, ME1 SRC 2538/4885L3MBTL1 4068/4885TDP1 4360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback